SOTT – Sign Of The Times
By Dr. Joseph Mercola
Mercola.com
Mon, 14 Mar 2022 00:00 UTC
Moderna produces one of three COVID shots available in the U.S.1 In November 2021, Moderna released data on third-quarter sales showing phenomenal profits from the vaccine of $5 billion worldwide and forecasted $18 billion for the year just from the mRNA vaccine.2 To take advantage of this revenue stream, the company announced they are developing three new mRNA vaccines for shingles, cancer and herpes.3
At the start of the vaccine race, the Health and Human Services Operation Warp Speed pledged to deliver 300 million doses of the vaccine by 2021.4 This was just months after the pandemic had been declared in early 2020. Yet, developing a safe and effective vaccine normally takes years and begins with animal studies.5